Releases

Releases

Category:

ı

Corporate Releases

ı

ı

Danish Releases

Jun 23, 2017 Corporate Releases	Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA
Jun 6, 2017 Press Releases	Lundbeck obtains rights to breakthrough research in Alzheimer's disease
May 31, 2017 Corporate Releases	Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
May 24, 2017 Corporate Releases	Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
May 24, 2017 Corporate Releases	Lundbeck increases its share capital by 823,364 shares (0.4166 % of outstanding shares) as a result of exercise of employee warrants
May 17, 2017 Corporate Releases	Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
May 11, 2017 Corporate Releases	Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
May 10, 2017 Corporate Releases	2017 guidance raised based on strong revenue growth and improved profitability
May 5, 2017 Corporate Releases	Lundbeck enters a conditional agreement and divests part of its headquarters in Copenhagen and expects to raise its financial guidance by DKK 200 million
May 2, 2017 Corporate Releases	Otsuka and Lundbeck announce improvement of agitation symptoms related to Alzheimer's-type dementia following treatment with brexpiprazole relative to placebo
Apr 28, 2017 Press Releases	Lundbeck awards Denmark's most talented young researchers
Mar 30, 2017 Corporate Releases	Lundbeck held its Annual General Meeting on 30 March 2017 at the company's registered office
Mar 1, 2017 Corporate Releases	Notice of Annual General Meeting
Feb 21, 2017 Corporate Releases	Lundbeck increases its share capital by 17,504 shares (0.0089 % of outstanding shares) as a result of exercise of employee warrants
Feb 8, 2017 Corporate Releases	Annual Report 2016 for H. Lundbeck A/S
Feb 8, 2017 Corporate Releases	Lundbeck continues to show solid revenue growth and strong improvement in profitability
Jan 25, 2017 Press Releases	Lundbeck and IBM Watson Health form collaboration on technology for developing innovative medicine

In order to comply with applicable regulation, press releases concerning a specific medicinal product are removed from our website within three weeks of publication. They can be retained upon request. Please contact us here.

You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.